As Table 5 depicts, there was no significant association between this variant and clinicopathological features in our study, except for PR status, which shows a significantly higher prevalence of the PR-positive DD genotype in BC patients (p = 0.031, Table 5). This evidence concerns the gene PGR and breast cancer.